|
HY-U00095-20mg
|
MedChemexpress LLC
|
Hepsulfam [CAS 96892-57-8]
|
|
Cancer-programmed cell death
|
|
|
HY-U00095-5mg
|
MedChemexpress LLC
|
Hepsulfam [CAS 96892-57-8]
|
|
Cancer-programmed cell death
|
|
|
HY-U00095-1mL
|
MedChemexpress LLC
|
Hepsulfam [CAS 96892-57-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-135366-10mg
|
MedChemexpress LLC
|
HPN-01 [CAS 928655-63-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135366-100mg
|
MedChemexpress LLC
|
HPN-01 [CAS 928655-63-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135366-25mg
|
MedChemexpress LLC
|
HPN-01 [CAS 928655-63-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135366-5mg
|
MedChemexpress LLC
|
HPN-01 [CAS 928655-63-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135366-50mg
|
MedChemexpress LLC
|
HPN-01 [CAS 928655-63-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-135366-1mL
|
MedChemexpress LLC
|
HPN-01 [CAS 928655-63-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-12501-10mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501-5mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501-50mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-10mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-5mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-50mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-1mL
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108944-10mg
|
MedChemexpress LLC
|
LYP-IN-1 [CAS 1404436-51-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-108944-100mg
|
MedChemexpress LLC
|
LYP-IN-1 [CAS 1404436-51-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-108944-25mg
|
MedChemexpress LLC
|
LYP-IN-1 [CAS 1404436-51-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-108944-5mg
|
MedChemexpress LLC
|
LYP-IN-1 [CAS 1404436-51-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-108944-50mg
|
MedChemexpress LLC
|
LYP-IN-1 [CAS 1404436-51-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-128035-1mg
|
MedChemexpress LLC
|
ML-211 [CAS 2205032-89-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
